Tenon Medical raises $1.125M net via 10% secured notes and warrants

Tenon Medical, Inc.

Sold $1.25M in secured notes (10% interest, due Nov 21, 2024) with warrants for 45,000 shares at $1.94.
Net proceeds of $1.125M after investor expenses; notes secured by first-priority lien on all assets.
Warrants exercisable immediately for five years, include cashless exercise and anti-dilution provisions.
Proceeds to be used for working capital and general corporate purposes.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Tenon Medical, Inc. entered into Securities Purchase Agreements with certain investors valued at $1,250,000 (effective 2023-11-21).

Action: entry
Agreement: equity purchase
Counterparty: certain investors
Value: $1,250,000
Effective: 2023-11-21

Exact text from the filing

On November 21, 2023, Tenon Medical, Inc. (the “Company”) entered into Securities Purchase Agreements (the “Purchase Agreements”) with certain investors (the “Investors”), pursuant to which the Company agreed to sell, issue and deliver to the Investors, in a private placement offering (the “Offering”), a total of $1,250,000 in secured notes (the “Notes”) and warrants (the “Warrants”)

View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

Tenon Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-090625

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.